Search for Clinical Trial Results
Carotid Artery Diseases - 26 Studies Found
Status | Study |
Completed |
Study Name: Carotid With Bivalirudin Angioplasty Condition: Carotid Artery Disease Date: 2008-12-18 Interventions: Device: RX ACCULINK™ Carotid Stent System; RX ACCUNET™ Embolic Protection System; PercuSurge GuardWire® 3-6 Temporary Occlusion and A |
Terminated |
Study Name: Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors Condition: Carotid Artery Disease Date: 2008-09-02 Interventions: Drug: Simvastatin All patients will start at 10mg of simvastatin, and then, based on results of interim |
Completed |
Study Name: Proximal Protection With The Mo.Ma Device During Carotid Stenting Condition: Carotid Artery Disease Date: 2008-08-29 Interventions: Device: Mo.Ma cerebral protection device Proximal embolic protection based on the principle endovascular |
Completed |
Study Name: A Carotid Stenting Boston Scientific Surveillance Program Condition: Carotid Artery Disease Date: 2008-08-25 Interventions:
|
Completed |
Study Name: The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue Condition: Carotid Artery Disease Date: 2007-12-21 Interventions:
|
Completed |
Study Name: CHOICE: Carotid Stenting For High Surgical-Risk Patients Condition: Carotid Artery Disease Date: 2006-11-29 Interventions: Device: RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 Provide an ongoing post-market |
Completed |
Study Name: SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy Condition: Carotid Artery Disease Date: 2006-11-20 |
Completed |
Study Name: Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) Condition: Carotid Artery Disease Date: 2006-11-20 Interventions: Device: Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3) All subjects will receive th |
Completed |
Study Name: CAPTURE 2 Post-Marketing Registry Condition: Carotid Artery Disease Date: 2006-03-10 Interventions: Device: RX ACCULINK, RX ACCUNET Embolic Protection System 1) To provide an ongoing post-market surveilla |
Completed |
Study Name: Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) Condition: Carotid Artery Disease Date: 2005-10-03 Interventions:
|